A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 1b/2a Study of WVE-120102 Administered Intrathecally in Patients with Huntington’s Disease

  • Kempster, Peter (Primary Chief Investigator (PCI))

Project: Research

Project Details

Project Description

NMA HREC Reference Number: HREC/47565/MonH-2018-154958(v1)
Monash Health Ref: RES-18-0000-647A
SSA: SSA/47565/MonH-2019-167103(v1) dated 4 March 2019
Effective start/end date3/06/192/06/24


  • clinical trial
  • treatment efficacy
  • Huntington's disease